Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperkalemia in Heart Failure: Probably Not O"K"

Marat Fudim1,2, Justin L Grodin3, Robert J Mentz4,2

  • 1Division of Cardiology, Duke Clinical Research Institute, Durham, NC marat.fudim@duke.edu.

Journal of the American Heart Association
|May 24, 2018
PubMed
Summary

No abstract available in PubMed .

Keywords:
Editorialscardiovascular outcomesheart failurehyperkalemia

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of the Hemodynamic Gain Index in Patients With Hypertrophic Cardiomyopathy.

The American journal of cardiology·2026
Same author

Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Trial.

Journal of cardiac failure·2026
Same author

Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial.

JAMA cardiology·2026
Same author

Identifying Subclinical Transthyretin Cardiac Amyloidosis in V142I TTR Carriers: Design, Rationale, and Methods of the VISTA (Variant Imaging of Subclinical Transthyretin Amyloidosis) Study.

The American journal of cardiology·2026
Same author

Rationale and design of MUSIC-HFpEF: a phase 1b, pilot trial evaluating the safety and pharmacodynamic effects of AAV1.SERCA2A in heart failure with preserved ejection fraction.

Heart failure reviews·2026
Same author

Monitoring Disease Progression in Patients With Transthyretin Amyloid Cardiomyopathy.

JACC. Heart failure·2025